Literature DB >> 8212577

Myristoylation-enhanced binding of the HIV-1 Nef protein to T cell skeletal matrix.

T M Niederman1, W R Hastings, L Ratner.   

Abstract

The negative factor, Nef, of HIV-1 was found to associate to an extent of 16-42% with the detergent insoluble cytoskeletal fraction of T lymphocytes. Furthermore, Escherichia coli expressed Nef protein was found to bind during in vitro reactions with the cytoskeletal matrix to an extent of 30-50%. Cytoskeletal association of Nef was significantly enhanced by myristoylation. The specificity of the myristoylation-enhanced binding was demonstrated by the lack of an effect of myristoylation on binding of the HIV-1 Gag protein to the cytoskeleton. Cytoskeletal binding was saturable, and inhibited by high concentrations of sodium chloride, or with SDS or urea. Binding of Nef to the cytoskeletal matrix may be important in mediating its effects on HIV-1 replication.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8212577     DOI: 10.1006/viro.1993.1605

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

1.  HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions.

Authors:  Tamika D Campbell; Mahfuz Khan; Ming-Bo Huang; Vincent Craig Bond; Michael D Powell
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

2.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

3.  The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix.

Authors:  S Swingler; P Gallay; D Camaur; J Song; A Abo; D Trono
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  Nef of HIV-1 interacts directly with calcium-bound calmodulin.

Authors:  Nobuhiro Hayashi; Mamoru Matsubara; Yuji Jinbo; Koiti Titani; Yoshinobu Izumi; Norio Matsushima
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

Review 5.  Novel anti-HIV therapeutics targeting chemokine receptors and actin regulatory pathways.

Authors:  Mark Spear; Jia Guo; Yuntao Wu
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

6.  Reconstitution and molecular analysis of an active human immunodeficiency virus type 1 Nef/p21-activated kinase 2 complex.

Authors:  Alexa Raney; Lillian S Kuo; Laura L Baugh; John L Foster; J Victor Garcia
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Effects of microtubule modulators on HIV-1 infection of transformed and resting CD4 T cells.

Authors:  Alyson Yoder; Jia Guo; Dongyang Yu; Zongqiang Cui; Xian-En Zhang; Yuntao Wu
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

8.  HIV-1 triggers WAVE2 phosphorylation in primary CD4 T cells and macrophages, mediating Arp2/3-dependent nuclear migration.

Authors:  Mark Spear; Jia Guo; Amy Turner; Dongyang Yu; Weifeng Wang; Beatrix Meltzer; Sijia He; Xiaohua Hu; Hong Shang; Jeffrey Kuhn; Yuntao Wu
Journal:  J Biol Chem       Date:  2014-01-10       Impact factor: 5.157

9.  HIV-1 Nef perturbs artificial membranes: investigation of the contribution of the myristoyl anchor.

Authors:  Ruth Szilluweit; Annegret Boll; Sonja Lukowski; Holger Gerlach; Oliver T Fackler; Matthias Geyer; Claudia Steinem
Journal:  Biophys J       Date:  2009-04-22       Impact factor: 4.033

Review 10.  HIV-1 Nef in macrophage-mediated disease pathogenesis.

Authors:  Susanna L Lamers; Gary B Fogel; Elyse J Singer; Marco Salemi; David J Nolan; Leanne C Huysentruyt; Michael S McGrath
Journal:  Int Rev Immunol       Date:  2012-12       Impact factor: 5.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.